A study on selective killing effect of Hsv-tk/GCV driven by human telomerase catalytic subunit promoter on human lung cancer cell A549

Chinese Journal of Medical Genetics

Volumn 24, Issue 2, 2007, Pages 148-152

  Tang, Xiao Jun ^a   Wang, Yan Ping ^a   Zhou, Qing Hua ^a   Che, Guo Wei ^a   Chen, Xiao He ^b   Zhu, Da Xing ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

Human telomerase catalytic subunit; Lung cancer; Selective expression; Suicide gene

Indexed keywords

GANCICLOVIR; MESSENGER RNA; TELOMERASE REVERSE TRANSCRIPTASE; THYMIDINE KINASE;

APOPTOSIS; ARTICLE; CANCER CELL; CATALYSIS; CELL CYCLE; CELL PROLIFERATION; COLORIMETRY; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC TRANSFECTION; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG ADENOCARCINOMA; LUNG FIBROBLAST; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIMIAN VIRUS 40; SUICIDE GENE; SUICIDE GENE THERAPY;

ANTIVIRAL AGENTS; APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; FLOW CYTOMETRY; GANCICLOVIR; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE THERAPY; HUMANS; LUNG NEOPLASMS; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIMPLEXVIRUS; TELOMERASE; THYMIDINE KINASE; TRANSFECTION; VIRAL PROTEINS;

SIMPLEXVIRUS;

EID: 34247253815     PISSN: 10039406     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Li YM, Song ST, Jiang ZF, et al. hTERT promoter regulated replication-selective adenovirus CNHK300 in treatment of hepatocellular carcinoma. Natl Med J China, 2005, 85:468-472.
2. Pulkkanen KJ, Parkkinen JJ, Laukkanen JM, et al. HSV-TK gene therapy for human renal cell carcinoma in nude mice. Cancer Gene Ther, 2001, 8: 529-536.
3. Tarsk TW, Trask RP, AguilarCordova E, et al. Phase I study of adenoviral delivery of the HSV-TK gene and ganciclovir administration in patients with current malignant brain tumors. Mol Ther, 2000, 1:195-203.
4. Hahn WC, Meyerson M. Telomerase activation, cellular immortalization and cancer. Ann Med, 2001, 33:123-129.
5. Wang YP, Tang XJ, Chen XH, et al. Study on cloning of hTERT promoter and its targeting transcriptional activities in telomerase-positive lung cancer cells. J Sichuan Univ(Med Sci Edi), 2006, 43:497-501.
6. Springer CJ, Niculescu-Duvaz I. Prodrug-activating systems in suicide gene therapy. J Clin Invest, 2000, 105:1161-1167.
7. Rainov NG. A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme. Hum Gene Ther, 2000, 11:2389-2401.
8. Herraiz M, Beraza N, Solano A, et al. Liver failure caused by herpes simplex virus thymidine kinase plus ganciclovir therapy is associated with mitochondrial dysfunction and mitochondrial DNA depletion. Hum Gene Ther, 2003, 4:463-472.
9. Jia LT, Wang CJ, Yang AG. Strategies of tumor-targeted gene therapy. Chin Oncol, 2003, 13:174-177.
10. Tracy R, David GH. Transcriptional targeting in cancer gene therapy. J Biomed Biotech, 2003, 2:110-137.
11. Wick M, Zubow D, Hagen G. Genomic organization and promoter characterization of the gene encoding the human telomerase reverse transcriptase (hTERT). Gene, 1999, 232:97-106.
12. Huang JJ, Li JZ, Lin J, et al. Cloning and characterization of human telomerase catalytic subunit (hTERT) gene promoter. Letters Biotechnol, 1990, 10:167-170.
13. Koga S, Hrohata S, Kondo Y, et al. A novel telomerase-specific gene therapy: gene transfer of caspase-8 utilizing the human telomerase catalytic subunit gene promoter. Hum Gene Ther, 2000, 11:1397-1406.
14. Komata T, Koga S, Hirohata S, et al. A novel treatment of human malignant gliomas in vitro and in vivo: FADD gene transfer under the control of the human telomerase reverse transcriptase gene promoter. Int J Oncol, 2001, 19:1015-1020.
15. Song JS. Adenovirus-mediated suicide SCLC gene therapy using the increased activity of the hTERT promoter by the MMRE and SV40 enhancer. Biosci Biotechnol Biochem, 2005, 69:56-62.